Background Early chemotherapy might improve the overall outcomes of patients with metastatic
non-castrate (ie, hormone-sensitive) prostate cancer. We investigated the effects of the …

PURPOSE: To better identify prognostic factors for local control and survival, as well as the
role of different therapeutic options, for phyllodes tumors, a rare fibroepithelial neoplasm of …

Purpose The delivery of bad news by oncologists to their patients is a key moment in the
physician-patient relationship. We performed a systematic review of qualitative studies (a …

Background. Angiosarcomas account for <2% of all soft tissue sarcomas. This subtype is
one of the most aggressive forms of soft tissue sarcoma. The prognosis for angiosarcoma …

Context Although antiangiogenic treatments and immunotherapies have significantly
improved the prognosis of metastatic renal cell carcinoma (RCC), many patients will develop …

BACKGROUND AND PURPOSE: Breast sarcoma (BS) is a rare tumour. While surgical
resection is the primary treatment, the role of radiation therapy (RT) and chemotherapy remains …

Cancers are heterogeneous at the cell level, and the mechanisms leading to cancer heterogeneity
could be clonal evolution or cancer stem cells. Cancer stem cells are resistant to most …

Background The Glass model developed in 2003 uses prognostic factors for noncastrate
metastatic prostate cancer (NCMPC) to define subgroups with good, intermediate, and poor …

CONTEXT: Hereditary renal cancers (HRCs) comprise approximately 3–5% of renal cell
carcinomas (RCCs). OBJECTIVE: Our aim was to provide an overview of the currently known …

Background Patients’ quality of life has become a major objective of care in oncology. At the
same time, it has become the object of increasing interest by researchers, working with both …